These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18060842)

  • 1. HIV-1 T-cell vaccines: evaluating the next step.
    Pantaleo G
    Lancet Infect Dis; 2008 Feb; 8(2):82-3. PubMed ID: 18060842
    [No Abstract]   [Full Text] [Related]  

  • 2. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
    [No Abstract]   [Full Text] [Related]  

  • 3. Human versus HIV: round 2 defeat in AIDS vaccine development.
    Lu S
    Expert Rev Vaccines; 2008 Mar; 7(2):151-3. PubMed ID: 18324884
    [No Abstract]   [Full Text] [Related]  

  • 4. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Bråve A; Hallengärd D; Schröder U; Blomberg P; Wahren B; Hinkula J
    Vaccine; 2008 Sep; 26(40):5075-8. PubMed ID: 18450334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vectors as HIV-1 vaccines: where are we? What next?
    DʼSouza MP; Yang OO
    AIDS; 2015 Feb; 29(4):395-400. PubMed ID: 25630039
    [No Abstract]   [Full Text] [Related]  

  • 6. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential vaccination strategy focuses on reactivating latent HIV.
    Patience J
    Expert Rev Anti Infect Ther; 2012 May; 10(5):526. PubMed ID: 22702324
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors.
    Casimiro DR; Bett AJ; Fu TM; Davies ME; Tang A; Wilson KA; Chen M; Long R; McKelvey T; Chastain M; Gurunathan S; Tartaglia J; Emini EA; Shiver J
    J Virol; 2004 Oct; 78(20):11434-8. PubMed ID: 15452269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of adenovirus in vaccines for HIV.
    Patterson S; Papagatsias T; Benlahrech A
    Handb Exp Pharmacol; 2009; (188):275-93. PubMed ID: 19031031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal immune status influences HIV-specific immune responses in pups after DNA prime protein boost using mucosal adjuvant.
    Bråve A; Johansen K; Palma P; Benthin R; Hinkula J
    Vaccine; 2008 Nov; 26(47):5957-66. PubMed ID: 18801400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS/HIV. A STEP into darkness or light?
    Moore JP; Klasse PJ; Dolan MJ; Ahuja SK
    Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccine test to be expanded based on upbeat results.
    AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenovirus 5 serotype vector-specific immunity and HIV-1 infection: a tale of T cells and antibodies.
    D'Souza MP; Frahm N
    AIDS; 2010 Mar; 24(6):803-9. PubMed ID: 20168203
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What next? Newspaper Article.
    Kresge KJ
    IAVI Rep; 2007; 11(5):13-4. PubMed ID: 20214014
    [No Abstract]   [Full Text] [Related]  

  • 19. STEP trial and HIV-1 vaccines inducing T-cell responses.
    Hanke T
    Expert Rev Vaccines; 2008 Apr; 7(3):303-9. PubMed ID: 18393600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Mosaic' HIV vaccine to be tested in thousands of people across the world.
    Mega ER
    Nature; 2019 Aug; 572(7768):165-166. PubMed ID: 31388154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.